文献速递血栓与止血

凝血因子VIII向CD4+ T细胞的转运塑造其免疫原性并需要多种抗原呈递细胞参与

Factor VIII trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen-presenting cells.
PubMed 文献 · Blood · 2023-01-01

本文探讨血友病A替代治疗中最严重并发症——凝血因子VIII(FVIII)抑制物形成的体内机制。研究显示FVIII抗原呈递至CD4+ T细胞关键依赖于一组解剖位置不同的抗原呈递细胞,边缘区B细胞、边缘区和边缘嗜金属巨噬细胞参与将FVIII转运至白髓,在那里常规树突状细胞(DCs)致敏辅助T细胞,后者分化为滤泡辅助T(Tfh)细胞。Toll样受体9刺激加速Tfh细胞反应、生发中心和抑制物形成,而单独全身给予FVIII可增加单核细胞来源和浆细胞样DCs频率。FVIII还增强T细胞对另一种蛋白抗原(卵清蛋白)的增殖,炎症信号缺陷小鼠更不易产生抑制物,提示FVIII可能具有内在免疫刺激特性。与FVIII不同,卵清蛋白被红髓巨噬细胞(RPMFs)区室吸收,以与FVIII相同剂量给药时不能引发T细胞增殖和抗体反应。作者提出,导致体内有效递送至DCs并激活炎症信号的抗原转运模式塑造了FVIII的免疫原性。

要点

  • FVIII抗原呈递至CD4+ T细胞依赖于边缘区B细胞、边缘区和边缘嗜金属巨噬细胞及常规DCs等多种抗原呈递细胞。
  • TLR9刺激加速Tfh细胞反应、生发中心和抑制物形成。
  • FVIII可能具有内在免疫刺激特性,而卵清蛋白被RPMFs区室吸收后不引发T细胞和抗体反应。

核心结论

  • 导致体内有效递送至树突状细胞并激活炎症信号的抗原转运模式塑造了FVIII的免疫原性。

研究设计与样本

  • 基础免疫学研究,使用血友病A小鼠模型探讨FVIII抑制物形成的体内细胞机制。

主要发现

  • FVIII抗原呈递至CD4+ T细胞关键依赖于边缘区B细胞、边缘区和边缘嗜金属巨噬细胞(而非红髓巨噬细胞RPMFs)将FVIII转运至白髓,在那里常规树突状细胞(DCs)致敏辅助T细胞,后者分化为滤泡辅助T(Tfh)细胞。
  • Toll样受体9刺激加速Tfh细胞反应、生发中心和抑制物形成,而单独全身给予FVIII可增加单核细胞来源和浆细胞样DCs频率。
  • FVIII增强T细胞对卵清蛋白的增殖,炎症信号缺陷小鼠更不易产生抑制物;卵清蛋白被RPMFs区室吸收,以与FVIII相同剂量给药时不引发T细胞增殖和抗体反应。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite >80 years of clinical experience with coagulation factor VIII (FVIII) inhibitors, surprisingly little is known about the in vivo mechanism of this most serious complication of replacement therapy for hemophilia A. These neutralizing antidrug alloantibodies arise in ∼30% of patients. Inhibitor formation is T-cell dependent, but events leading up to helper T-cell activation have been elusive because of, in part, the complex anatomy and cellular makeup of the spleen. Here, we show that FVIII antigen presentation to CD4+ T cells critically depends on a select set of several anatomically distinct antigen-presenting cells, whereby marginal zone B cells and marginal zone and marginal metallophilic macrophages but not red pulp macrophages (RPMFs) participate in shuttling FVIII to the white pulp in which conventional dendritic cells (DCs) prime helper T cells, which then differentiate into follicular helper T (Tfh) cells. Toll-like receptor 9 stimulation accelerated Tfh cell responses and germinal center and inhibitor formation, whereas systemic administration of FVIII alone in hemophilia A mice increased frequencies of monocyte-derived and plasmacytoid DCs. Moreover, FVIII enhanced T-cell proliferation to another protein antigen (ovalbumin), and inflammatory signaling-deficient mice were less likely to develop inhibitors, indicating that FVIII may have intrinsic immunostimulatory properties. Ovalbumin, which, unlike FVIII, is absorbed into the RPMF compartment, fails to elicit T-cell proliferative and antibody responses when administered at the same dose as FVIII. Altogether, we propose that an antigen trafficking pattern that results in efficient in vivo delivery to DCs and inflammatory signaling, shape the immunogenicity of FVIII.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Kaczmarek R, Piñeros AR, Patterson PE, et al. Factor VIII trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen-presenting cells. Blood. 2023. PMID: 37192286. doi:10.1182/blood.2022018937

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。